These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7666121)

  • 1. Comparative activities of pefloxacin and ciprofloxacin in the treatment of chronic respiratory tract infections.
    Scaglione F; Scamazzo F; Arcidiacono MM; Cogo R; Monzani GP; Fraschini F
    J Chemother; 1995 Apr; 7(2):140-5. PubMed ID: 7666121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro activity of 3 fluoroquinolones on Branhamella catarrhalis].
    Suermondt G; Denamur E; Laurans G; Orfila J
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):647-50. PubMed ID: 3141885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The pharmacodynamics and pharmacokinetics of fluoroquinolones in the evaluation of antibacterial therapy regimens].
    Smirnova LB; Sokolova VI
    Antibiot Khimioter; 2000; 45(7):14-6. PubMed ID: 10987102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum pharmacokinetics and in vitro antibacterial activity of pefloxacin, ofloxacin and ciprofloxacin].
    Nordmann P; Jarlier V
    Presse Med; 1990 Sep 1-8; 19(28):1321-5. PubMed ID: 2145562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication.
    Peloquin CA; Cumbo TJ; Nix DE; Sands MF; Schentag JJ
    Arch Intern Med; 1989 Oct; 149(10):2269-73. PubMed ID: 2508586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis.
    Dellamonica P; Bernard E; Etesse H; Garraffo R; Drugeon HB
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1024-30. PubMed ID: 2515961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro comparative activity of moxifloxacin and other antimicrobials against respiratory pathogens].
    Prado V; Giangrieco M; Durán C; Ojeda A; van Flaskamp R
    Rev Med Chil; 2000 Dec; 128(12):1319-26. PubMed ID: 11227240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro activity of trovafloxacin in 238 respiratory pathogens].
    Alarcón T; Domingo D; Prieto N; Sánchez S; López-Brea M
    Rev Esp Quimioter; 1998 Mar; 11(1):47-51. PubMed ID: 9795289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The antimicrobial activity of fluoroquinolone agents against pathogenic organisms in respiratory tract infections and its clinical effect].
    Akiyama M; Takahashi A; Nagatake T; Yamashita H; Yoshida T; Rikitomi N; Ohishi K; Tanaka H; Morito T; Utsunomiya Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Sep; 28(9):1174-81. PubMed ID: 2176251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary penetration of ceftazidime.
    Cazzola M; Gabriella Matera M; Polverino M; Santangelo G; De Franchis I; Rossi F
    J Chemother; 1995 Feb; 7(1):50-4. PubMed ID: 7629560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R; Griggs D; Andrews JM
    Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of the new quinolones, ciprofloxacin and pefloxacin in experimental plague].
    Kasatkina IV; Sherbaniuk AI; Makarovskaia LN; Padeĭskaia EN
    Antibiot Khimioter; 1993 Jan; 38(1):42-5. PubMed ID: 8060184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative efficacy and safety of ciprofloxacin, ofloxacin, and pefloxacin in treatment of respiratory infections in children with cystic fibrosis].
    Postnikov SS
    Antibiot Khimioter; 2001; 46(3):16-20. PubMed ID: 11548276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and pharmacokinetic study of pefloxacin in spontaneous ascitic fluid infections].
    Ducroix JP; Hary L; Andrejak M; Smail A; Tondriaux A; Eb F; Baillet J
    Therapie; 1990; 45(6):461-5. PubMed ID: 2080483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New oral quinolone compounds in chronic bronchitis].
    Davies BI; Maesen FP; Teengs JP; Baur C
    Infection; 1986; 14 Suppl 1():S73-8. PubMed ID: 2937739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].
    Wang H; Liu YL; Chen MJ; Xu YC; Sun HL; Yang QW; Hu YJ; Cao B; Chu YZ; Liu Y; Zhang R; Yu YS; Sun ZY; Zhuo C; Ni YX; Hu BJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):113-9. PubMed ID: 22455967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of efficacy and tolerability among 3 quinolones in the treatment of lower urinary tract infections (cinoxacin versus ciprofloxacin and pefloxacin].
    Sesia G; Cauda F; Alladio F
    Minerva Urol Nefrol; 1992; 44(3):217-8. PubMed ID: 1492275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
    Nord CE; Lindmark A; Persson I
    J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of three newer quinolones in pregnant and lactating women.
    Giamarellou H; Kolokythas E; Petrikkos G; Gazis J; Aravantinos D; Sfikakis P
    Am J Med; 1989 Nov; 87(5A):49S-51S. PubMed ID: 2589384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections.
    Fass RJ; Plouffe JF; Russell JA
    Am J Med; 1989 Nov; 87(5A):164S-168S. PubMed ID: 2589361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.